Severe stomatitis caused by osimertinib combined with gefitinib: A case report.

Clin Case Rep · 2022 · PMC8843833 · PMID 35223006

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Although the mutation sites of the two cases are different, the effectiveness of the combination therapy is highly significant and indicates that the underlying mechanism needs further investigation.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.